FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2956358112> ?p ?o ?g. }

• W2956358112 abstract "Reactive focal mass drug administration (rfMDA), or presumptive treatment without malaria testing of household members and neighbours of a passively identified malaria case, is currently being explored as a possible malaria elimination strategy in low transmission settings. One of the primary factors determining the effectiveness of rfMDA on reducing or interrupting transmission is achieving high coverage of the target population with drug administration. This study aims to explore the acceptability of rfMDA and identify facilitators and barriers to its potential implementation, as well as the community’s general knowledge, attitudes and beliefs with regard to malaria elimination. A qualitative study was performed using focus group discussions (FGDs) among villagers that received rfMDA through the National Malaria Control Programme in the low transmission setting of Eswatini as part of a 2-year clinical trial. FGDs were audio-recorded, transcribed and translated into English. All transcripts were managed in Dedoose and underwent qualitative content analysis. The majority of participants perceived their community to be at high risk of malaria. Witnessing others in their community suffer from malaria, proximity to Mozambique, various ecological factors, and the presence of mosquitoes contributed to this perception. The greatest motivator of participation in rfMDA was witnessing someone else suffer from malaria, since most participants had not personally experienced malaria themselves. Participants valued the education on rfMDA and on malaria in general, particularly when communicated by nurses and other health workers from the Ministry of Health. Participants were overwhelmingly motivated to participate in rfMDA in order to obtain protection from malaria. Most participants did not understand the concept of sub-clinical infection and, therefore, did not perceive the anti-malarial medication given in rfMDA to be a treatment medication. Perceived risk for malaria was a major driver of acceptability; therefore, future intervention campaigns could aim to better quantify risk to inform interventions and encourage uptake. There were misunderstandings about the asymptomatic reservoir of parasites in humans. Given that this phenomenon is the rationale for rfMDA, this misunderstanding could threaten the uptake of the intervention if it persists in the community. Using local authorities to deliver messaging, additional education on this concept with re-inforcement that risk of malaria is ongoing, even in the absence of frequent cases, may help to maximize and maintain acceptability." @default.
• W2956358112 created "2019-07-23" @default.
• W2956358112 creator A5008906741 @default.
• W2956358112 creator A5016397784 @default.
• W2956358112 creator A5019889278 @default.
• W2956358112 creator A5022271104 @default.
• W2956358112 creator A5025907369 @default.
• W2956358112 creator A5026410206 @default.
• W2956358112 creator A5043212187 @default.
• W2956358112 creator A5046916649 @default.
• W2956358112 creator A5049912579 @default.
• W2956358112 creator A5080802234 @default.
• W2956358112 creator A5090129379 @default.
• W2956358112 date "2019-07-15" @default.
• W2956358112 modified "2023-10-15" @default.
• W2956358112 title "“We were afraid of the lion that has roared next to us”; community response to reactive focal mass drug administration for malaria in Eswatini (formerly Swaziland)" @default.
• W2956358112 cites W2007427909 @default.
• W2956358112 cites W2007441047 @default.
• W2956358112 cites W2023031926 @default.
• W2956358112 cites W2030271226 @default.
• W2956358112 cites W2041200787 @default.
• W2956358112 cites W2052028492 @default.
• W2956358112 cites W2060493366 @default.
• W2956358112 cites W2112222406 @default.
• W2956358112 cites W2114625697 @default.
• W2956358112 cites W2134740567 @default.
• W2956358112 cites W2160964693 @default.
• W2956358112 cites W2166709641 @default.
• W2956358112 cites W2524256616 @default.
• W2956358112 cites W2549012749 @default.
• W2956358112 cites W2555838895 @default.
• W2956358112 cites W2560080836 @default.
• W2956358112 cites W2589130199 @default.
• W2956358112 cites W2599187129 @default.
• W2956358112 cites W2615045196 @default.
• W2956358112 cites W2619447654 @default.
• W2956358112 cites W2735214835 @default.
• W2956358112 cites W2783983357 @default.
• W2956358112 cites W2788929045 @default.
• W2956358112 cites W2793184643 @default.
• W2956358112 cites W2793711844 @default.
• W2956358112 cites W2802237363 @default.
• W2956358112 cites W2904360036 @default.
• W2956358112 cites W2970935231 @default.
• W2956358112 cites W4247935553 @default.
• W2956358112 cites W4251155849 @default.
• W2956358112 doi "https://doi.org/10.1186/s12936-019-2877-9" @default.
• W2956358112 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6631448" @default.
• W2956358112 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31307494" @default.
• W2956358112 hasPublicationYear "2019" @default.
• W2956358112 type Work @default.
• W2956358112 sameAs 2956358112 @default.
• W2956358112 citedByCount "9" @default.
• W2956358112 countsByYear W29563581122020 @default.
• W2956358112 countsByYear W29563581122021 @default.
• W2956358112 countsByYear W29563581122023 @default.
• W2956358112 crossrefType "journal-article" @default.
• W2956358112 hasAuthorship W2956358112A5008906741 @default.
• W2956358112 hasAuthorship W2956358112A5016397784 @default.
• W2956358112 hasAuthorship W2956358112A5019889278 @default.
• W2956358112 hasAuthorship W2956358112A5022271104 @default.
• W2956358112 hasAuthorship W2956358112A5025907369 @default.
• W2956358112 hasAuthorship W2956358112A5026410206 @default.
• W2956358112 hasAuthorship W2956358112A5043212187 @default.
• W2956358112 hasAuthorship W2956358112A5046916649 @default.
• W2956358112 hasAuthorship W2956358112A5049912579 @default.
• W2956358112 hasAuthorship W2956358112A5080802234 @default.
• W2956358112 hasAuthorship W2956358112A5090129379 @default.
• W2956358112 hasBestOaLocation W29563581121 @default.
• W2956358112 hasConcept C119599485 @default.
• W2956358112 hasConcept C127413603 @default.
• W2956358112 hasConcept C138816342 @default.
• W2956358112 hasConcept C144024400 @default.
• W2956358112 hasConcept C159110408 @default.
• W2956358112 hasConcept C190248442 @default.
• W2956358112 hasConcept C19165224 @default.
• W2956358112 hasConcept C203014093 @default.
• W2956358112 hasConcept C2778048844 @default.
• W2956358112 hasConcept C2780133432 @default.
• W2956358112 hasConcept C2908647359 @default.
• W2956358112 hasConcept C36289849 @default.
• W2956358112 hasConcept C512399662 @default.
• W2956358112 hasConcept C56995899 @default.
• W2956358112 hasConcept C71924100 @default.
• W2956358112 hasConcept C761482 @default.
• W2956358112 hasConcept C99454951 @default.
• W2956358112 hasConceptScore W2956358112C119599485 @default.
• W2956358112 hasConceptScore W2956358112C127413603 @default.
• W2956358112 hasConceptScore W2956358112C138816342 @default.
• W2956358112 hasConceptScore W2956358112C144024400 @default.
• W2956358112 hasConceptScore W2956358112C159110408 @default.
• W2956358112 hasConceptScore W2956358112C190248442 @default.
• W2956358112 hasConceptScore W2956358112C19165224 @default.
• W2956358112 hasConceptScore W2956358112C203014093 @default.
• W2956358112 hasConceptScore W2956358112C2778048844 @default.
• W2956358112 hasConceptScore W2956358112C2780133432 @default.
• W2956358112 hasConceptScore W2956358112C2908647359 @default.
• W2956358112 hasConceptScore W2956358112C36289849 @default.
• W2956358112 hasConceptScore W2956358112C512399662 @default.
• W2956358112 hasConceptScore W2956358112C56995899 @default.

• next